Pat McAfee calls out 'bum a-- suits' at ESPN while congratulating network's WWE deal
But the ESPN host called out some employees within his own company in the process.
McAfee posted on X congratulating ESPN and WWE on finalizing a deal, which was announced Wednesday.
"Great to see 2 powerhouses of sports and entertainment come together," McAfee wrote before taking his shot.
"I assume all the mid level, powerless, bum a--suits at ESPN will attempt to muddy this somehow (out of context leaks/ignorant anonymous opinions/etc.) but, in the end.. this agreement will outlive the dinosaurs currently guarding desks in Bristol and this deal will be great for ESPN.
"Cheers to the future."
McAfee has had issues in the past with ESPN executives, which could've led to his jab. He accused Norby Williamson on air, saying the longtime executive tried to "sabotage" his show in 2024. Williamson ended up moving on to FanDuel Sports Network after spending 40 years at the "Worldwide Leader in Sports."
The WWE-ESPN deal has been reported to be worth $1.6 billion over five years.
This will allow ESPN to broadcast some of the most anticipated WWE events each year, like WrestleMania, Summer Slam and the Royal Rumble as part of the pro wrestling giant's direct-to-consumer service launching in late August.
McAfee is a big wrestling fan, having served as a commentator for the WWE. However, he stepped away from that earlier this year due to a busy schedule.
But he is clearly aware of the deal, and he has never shied away from speaking his mind even after joining ESPN on a five-year, $85 million deal.
"I don't got a motherf---ing boss," he said in the past.
ESPN made another landmark deal in the world of sports.
The network announced Tuesday it acquired the NFL Network in a deal that gave the league a 10% equity stake in ESPN.
The deal includes the NFL's linear RedZone Channel, NFL Fantasy and more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
a few seconds ago
- Newsweek
AEW Superstar Undergoes Surgery
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. AEW star Buddy Matthews is set to be on the sidelines for the foreseeable future. The House of Black member confirmed on Thursday that he is undergoing ankle surgery. In a post on his Instagram story, Matthews shared a photo of himself at a hospital. He was alongside his real-life partner, former WWE Women's World Champion Rhea Ripley, just before he went in for the procedure. Buddy Matthews is getting surgery to repair his ankle. Speedy recovery. — Andrew Ravens l (@Andrew_Ravens) August 7, 2025 A Sidelined House Of Black Member Matthews has been largely absent from AEW programming in recent weeks. This surgery now provides a legitimate reason for his time away from the ring as he begins his recovery. The specific nature of the ankle injury and a potential timetable for his return have not yet been disclosed. His absence further complicates the status of the House of Black faction, as fellow member Brody King has recently been competing in the AEW World Tag Team Title Eliminator Tournament with a new partner, Bandido. From "Best Kept Secret" to House Of Black Buddy Matthews has had a decorated career in both WWE and AEW. WWE fans will remember him from his time in NXT, where he was a one-time NXT Tag Team Champion. He later had a career-defining run on the 205 Live brand, where he was repackaged as "The Best Kept Secret" and had a dominant, critically acclaimed reign as the WWE Cruiserweight Champion. All Elite Wrestling ALL IN at Wembley Stadium in London on August 27, 2023. All Elite Wrestling ALL IN at Wembley Stadium in London on August 27, 2023. Courtesy of AEW More news: WWE Superstar Announces Retirement Match After his WWE release, he made his debut for AEW in 2022. He was revealed as the third member of the dark and mysterious faction, the House of Black, alongside Malakai Black and Brody King. An Uncertain Future The House of Black quickly became one of the most popular and dominant groups in AEW. Their biggest success came when they captured the AEW World Trios Championship and held the titles for a significant portion of 2023. This injury is an unfortunate setback for the talented Australian star. The wrestling world now wishes him a full and speedy recovery and awaits the eventual, and likely ominous, return of the full House of Black. More WWE News: For more on WWE, head to Newsweek Sports.
Yahoo
28 minutes ago
- Yahoo
BlinkRx Launches "Operation Access Now" to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs
Operation Access Now enables pharmaceutical manufacturers to launch direct‑to‑patient programs within 21 days NEW YORK, August 07, 2025--(BUSINESS WIRE)--BlinkRx, the nation's leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid deployment initiative that enables pharmaceutical manufacturers to build and launch direct-to-patient (DTP) and direct‑to‑business (DTB) channels that expand medication access and deliver pricing transparency in as little as 21 days. This program comes at a moment of growing urgency across the life sciences industry. As traditional access models struggle to meet patient and provider expectations, leading brands are turning to faster, more scalable approaches. BlinkRx's national infrastructure already supports millions of patients across all 50 states. The platform's patient-centric design removes every barrier for patients to start and stay on therapy and delivers significant lift for brands: on average, 52% more patient starts and 41% more fills per patient. With Operation Access Now, the initiative enables: Rapid Stand‑Up: DTP programs that can be operational in as little as 21 days, thanks to BlinkRx's turnkey platform and flexible rules engine. Future-Proof: A modular platform that allows pharmaceutical manufacturers to start with a DTP solution and expand into future capabilities as needs and regulations change. For example, the platform can be deployed for DTB models, and can service both cashpay and insurance patients. Scale: Unique automation capabilities that enable pharmaceutical manufacturers to effortlessly scale based on patient demand and adoption. Legacy DTP solutions, such as copay cards and standalone cash pharmacies, are often costly, inefficient, and prone to patient and physician frustration- causing delays in access, misuse, and poor experiences. BlinkRx's platform addresses these ecosystem issues while ensuring strict regulatory compliance. "Operation Access Now is about removing every barrier between manufacturers and the patients who need their therapies," said Geoffrey Chaiken, Co‑Founder and CEO of BlinkRx. "We're prepared to enable manufacturers to deploy DTP programs and deliver the speed, scale, and flexibility the market demands." About BlinkRx BlinkRx is a Prescription Lifecycle Management Platform that allows the most innovative Life Sciences companies to design every aspect of the prescription journey to unlock branded medication affordability and access for all Americans. Learn more at View source version on Contacts For media inquiries, please contact: Press@
Yahoo
28 minutes ago
- Yahoo
Crocs Sinks Most Since March 2020 on Tariffs, Cautious Consumers
(Bloomberg) -- Crocs Inc. shares dropped the most since the start of the Covid-19 pandemic on a weaker outlook, with the maker of colorful clogs warning that cautious consumers are further pulling back on spending. All Hail the Humble Speed Hump Mayor Asked to Explain $1.4 Billion of Wasted Johannesburg Funds Three Deaths Reported as NYC Legionnaires' Outbreak Spreads Major Istanbul Projects Are Stalling as City Leaders Sit in Jail PATH Train Service Resumes After Fire at Jersey City Station Third-quarter revenue will decline approximately 9% to 11%, the company said on Thursday, well below analysts' average estimate for a gain of less than 1%. On Crocs' earnings call with analysts, executives said they won't reinstate full-year guidance, which it first withdrew earlier this year, due to changing global trade policies. The stock fell as much as 29% in Thursday trading in New York, the most since March 2020. The drop pushed the shares' year-to-date decline to nearly 30%, versus a 7.7% increase for the Russell 3000 Index. Chief Executive Officer Andrew Rees said US consumers, faced with price increases, are behaving 'cautiously around discretionary spending.' This 'has the potential to be a further drag on an already choiceful consumer,' he added. 'They're not even going to the stores and we see traffic down,' he said, adding the current conditions are preventing the company from raising prices to compensate for the impact of tariffs on countries where Crocs produces footwear. Crocs joins companies such as Steve Madden Ltd. and Lululemon Athletica Inc. that have been hit simultaneously by economic uncertainty and higher tariffs on nations such as China, which produces a large volume of apparel and footwear. In the three months ended March 31, Crocs reported that China produced around 22% of products send to the US — a percentage the company plans to reduce. A 'predominant portion' of merchandise also comes from Vietnam, Indonesia, India and Cambodia. Crocs is focusing on managing its expenses through cost cuts, inventory reduction and fewer promotions. 'Crocs might have a tougher time navigating tariff pressures, given its decision to pull back on promotions to preserve brand image,' Bloomberg Intelligence analyst Abigail Gilmartin said in a note. --With assistance from Katerina Petroff and Micah Barkley. (Updates with conference call detail and shares trading.) The Pizza Oven Startup With a Plan to Own Every Piece of the Pie Russia's Secret War and the Plot to Kill a German CEO AI Flight Pricing Can Push Travelers to the Limit of Their Ability to Pay A High-Rise Push Is Helping Mumbai Squeeze in Pools, Gyms and Greenery Government Steps Up Campaign Against Business School Diversity ©2025 Bloomberg L.P. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
